Koninklijke Philips NV (BUE:PHG) Beta: N/A (As of Jul. 11, 2026)


BUE:PHG Koninklijke Philips NV BUE:PHG
56 GF Score
Price ARS8,605.00
GF Value ARS8,043.49
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-11), Koninklijke Philips NV's Beta is Not available.

Koninklijke Philips NV  (BUE:PHG) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Koninklijke Philips NV Beta Related Terms

Koninklijke Philips NV Beta Historical Data

* Premium members only.

The historical data trend for Koninklijke Philips NV's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koninklijke Philips NV Beta Chart

Koninklijke Philips NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Koninklijke Philips NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BUE:PHG
56GF Score
Koninklijke Philips NV BUE:PHG
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Koninklijke Philips NV Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Koninklijke Philips NV (BUE:PHG) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of ARS8,605.00 is trading 7% above its estimated GF Value™ of ARS8,043.49. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for BUE:PHG:

  • Beta: N/A
  • GF Value™: ARS8,043.49 vs. price of ARS8,605.00 (7% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the BUE:PHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
56GF Score

Get the complete analysis for BUE:PHG

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS8,605.00
Price
ARS8,043.49
GF Value